NEWS
The latest weapon in modern warfare?

By Barry Mattacott, marketing director, Wick Hill Group.

Read More
Storm clouds in 2016?

Mike Weston, CEO of data science consultancy Profusion, discusses what issues will impact...

Read More
NEWS
Top information security threats for 2016

As 2016 kicks off, leading cloud security company iSheriff has forecast the top five security...

Read More
2015 has been another eventful year for cyber security

Based on its current work with customers, Blue Coat has outlined what the cyber security world can...

Read More
NEWS
Key trends taking place over 2016

Cybersecurity expert Gerard Bauer, VP EMEA at Vectra Networks, offers some thoughts on key...

Read More
NEWS
Cyber insurance – Why it matters for the Cloud

By Chris Pace, Head of Product Marketing at Wallix UK.

Read More
NEWS
Top IT security threats in 2016

Netwrix sums up top seven security trends that will drive IT strategy and investment in 2016.

Read More

Videos

Barny Evans, Director of Sustainability and ESG at Turley, explains how the data centre industry can sustainably navigate the energy demands of the AI revolution, discussing innovative approaches to powering...
News and views from the recent DCA-organised Data Centre Transformation 2024 event.
Jad Jebara, President and CEO of Hyperview, introduces the recently unveiled suite of features which are being added to the company’s DCIM solution, with the new carbon footprint reporting system, providing...
News and views from the recent DCA-organised Data Centre Transformation 2024 event.

News

NTT DATA research shows organizations shifting from experiments to investments that drive performance.
This global service forms part of the recently launched Intelligent Security portfolio and increases Logicalis' proactive threat-hunting capabilities worldwide. It provides advanced visibility into cyberattack...
The Seeq platform will be leveraged to maximize production and increase energy efficiency across the largest biorefinery in Europe.
The promise of AI is on every biopharma’s radar, but the reality today is that much of the industry is grappling with how to convert the hype into impact.